Journals / The Anatolian Journal of Cardiology / 2015 / Cilt: 15 - Sayı: 2

A novel oral anticoagulant, dabigatran, in acute renal infarction

Pages
158–159
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ALTIN, C., SAKALLIOĞLU, O., GEZMİŞ, E., MÜDERRİSOĞLU, H. (2015). A novel oral anticoagulant, dabigatran, in acute renal infarction. The Anatolian Journal of Cardiology, Cilt: 15 - Sayı: 2, 158–159. https://ajindex.com/articles/367302

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Bourgault M, Grimbert P, Verret C, Pourrat J, Herody M, Halimi JM, et al. Acute renal infarction: a case series. Clin J Am Soc Nephrol 2013; 8: 392-8. [CrossRef] 2. Bolderman R, Oyen R, Verrijcken A, Knockaert D, Vanderschueren S. Idiopathic renal infarction. Am J Med 2006; 119: 356: e9-12. 3. Paris B, Bobrie G, Rossignol P, Le Coz S, Chedid A, Plouin PF. Blood pressure and renal outcomes in patients with kidney infarction and hypertension. J Hypertens 2006; 24: 1649-54. [CrossRef] 4. Antopolsky M, Simanovsky N, Stalnikowicz R, Salameh S, Hiller N. Renal infarction in the ED: 10-year experience and review of the literature. Am J Emerg Med 2012; 30: 1055-60. [CrossRef] 5. Mahamid M, Francis A, Abid A, Awawde M, Abu-Elhija O. Embolic renal infarction mimicking renal colic. Int J Nephrol Renovasc Dis 2014; 7: 157-9. [CrossRef] 6. Jeffrey RB, Federle MP. CT and ultrasonography of acute renal abnormalities. Radiol Clin North Am 1983; 21: 515-25. 7. Kim SH, Park JH, Han JK, Han MC, Kim S, Lee JS. Infarction of the kidney: role of contrast enhanced MRI. J Comput Assist Tomogr 1992; 16: 924-8. [CrossRef] 8. Moyer JD, Rao CN, Widrich WC, Olsson CA. Conservative management of renal artery embolus. J Urol 1974; 109: 138-43. 9. Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation 2011; 123: 2363-72. [CrossRef] 10. Wann LS, Curtis AB, Ellenbogen KA, Estes NA, Ezekowitz MD, Jackman WM, et al. American College of Cardiology Foundation/American Heart Association Task Force. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 123: 1144-50. [CrossRef]